VitaLonga

Clinical trial · Supplements / medicine · 14 Nov 2026

In 130 women after menopause, date palm pollen lined up with higher sexual-function scores over two months

Source: BMC Complementary Medicine and Therapies

What the research found

A double-blind randomized placebo-controlled trial was published online on 14 November 2026. 130 women after menopause were assigned to a date palm pollen supplement or placebo (65 and 65). Mean age was 52.3 years (standard deviation 3.1). Scores were taken at the start, at one month, and at two months. Group-by-time interactions for sexual function, sexual satisfaction, and sexual quality of life were all p<0.001. In the supplement group, the median sexual-function score moved from 18.5 to 26.2, satisfaction from 84 to 106, and sexual quality of life from 71 to 91.5. Placebo scores stayed about the same or fell slightly. The authors say baseline imbalances and the short follow-up mean the result should be read cautiously. The abstract does not give the dose. Registry IRCT20241204063940N1. DOI 10.1186/s12906-026-05674-y. Not medical advice.

Evidence level: Clinical trial. This is among the stronger kinds of evidence, but one study rarely settles a question.

Read the original at BMC Complementary Medicine and Therapies

More supplements / medicine news